PD-1/PD-L1-IN 5 structure
|
Common Name | PD-1/PD-L1-IN 5 | ||
---|---|---|---|---|
CAS Number | 2170209-51-3 | Molecular Weight | 418.47 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H18N4O3S | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PD-1/PD-L1-IN 5PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM[1]. |
Name | PD-1/PD-L1-IN 5 |
---|
Description | PD-1/PD-L1-IN 5 is a PD-1/PD-L1 protein/protein interaction inhibitor extracted from patent WO2017222976A1, compound Example 1, has an IC50 of ≤100 nM[1]. |
---|---|
Related Catalog | |
Target |
IC50: ≤100 nM (PD-1/PD-L1)[1] |
In Vitro | The compounds modulate PD-1/PD-L1 protein/protein interaction and are useful in the treatment of various diseases including infectious diseases and cancer. The compounds can be used as immunomodulators[1]. |
References |
[1]. Kaijiong Xiao, et al. Heterocyclic compounds as immunomodulators. WO2017222976A1. |
Molecular Formula | C22H18N4O3S |
---|---|
Molecular Weight | 418.47 |